A sponsor-open, randomized, placebo-controlled, phase I study to investigate the pharmacokinetics, safety, and tolerability of RO7223280 in healthy Chinese participants following single IV dose administration
-
Infectious Diseases
For the latest version of this information please go to www.forpatients.roche.com